Pharmaceuticals

• 11/4/2024

  Bristol Myers Squibb Smashes Q3 Earnings Expectations

• 11/3/2024

  Eli Lilly Stock: Buy the Dip or Sell the Stumble?

• 11/3/2024

  Biogen’s Q3 Earnings Beat Expectations, Driven by Alzheimer’s Breakthrough

• 11/3/2024

  Merck’s Q3 Earnings: Keytruda Soars, Vaccines Falter

• 11/1/2024

  Eli Lilly’s Weight Loss and Diabetes Drugs Miss Sales Expectations Amid Inventory Issues

• 11/1/2024

  Eli Lilly’s Q3 Earnings Disappoint: Sales of Blockbuster Drugs Fall Short

• 10/26/2024

  Navigating the Challenges of Acurx Pharmaceuticals: A Balanced Perspective

• 10/26/2024

  “Invest in a Leader: Why Novo Nordisk is a Top Pharmaceutical Stock”

• 10/25/2024

  Viatris Inc. Stock Update: Time to Reconsider?

• 10/25/2024

  “Cabaletta Bio: Unlocking the Power of CAR-T Compounds for Breakthrough Treatments”